突变Ter462GlnextTer17引入了蛋白C的C端的尾巴,并导致静脉血栓形成
Zhe Lai1, Jiaming Li2, Shijie Zhou1
1Department of Laboratory Medicine, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Thrombosis research
|June 2, 2024
概括
蛋白C (PC) 的新型突变损害了其激活和抗凝功能,增加了静脉血栓塞栓症 (VTE) 的风险. 这种遗传缺陷突出了PC.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 蛋白C (PC) 是一种依赖维生素K的血蛋白酶,对调节血液凝固至关重要.
- 活性蛋白C (APC) 通过非活性化Va和VIIIa因子来抑制血栓生成.
- 血小板缺陷是静脉血栓栓塞 (VTE) 的已知危险因素.
研究的目的:
- 为了研究在VTE患者中发现的一种新型异构性PROC突变 (c.1384T>C,p.Ter462GlnextTer17) 的功能后果.
- 为了阐明这种突变在血栓形成的病变发生过程中的作用.
主要方法:
- 在哺乳动物细胞中的重组PC-Ter462GlnextTer17的表达.
- 凝血试验包括激活研究,染色基质试验,APTT,FVa降解和血栓生成试验.
- 在纯化和基于等离子体的系统中评估突变蛋白的功能.
主要成果:
- Ter462GlnextTer17突变显著损害了由血栓素和血栓素-血栓模块素复合物的PC激活.
- 活性PC-Ter462GlnextTer17显著降低了水解和抗凝剂活性.
- 无论蛋白质S存在,都观察到抗凝功能受损.
结论:
- Ter462GlnextTer17突变导致C端延伸,损害了PC细胞原激活和APC抗凝功能.
- 这种突变代表了一种新的遗传风险因素,有助于血栓形成和静脉瘤发育.
相关概念视频
Mutations
81.8K
Overview
81.8K
Translation
14.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.8K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Tail-anchoring of Proteins in the ER Membrane
3.1K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.1K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K


